386 related articles for article (PubMed ID: 18408528)
1. A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia.
Perez V; Cañas F; Tafalla M;
Int Clin Psychopharmacol; 2008 May; 23(3):138-49. PubMed ID: 18408528
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
[TBL] [Abstract][Full Text] [Related]
3. The relationship between serum prolactin level and sexual functioning among male outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind trial of risperidone vs. quetiapine.
Nakonezny PA; Byerly MJ; Rush AJ
J Sex Marital Ther; 2007; 33(3):203-16. PubMed ID: 17454518
[TBL] [Abstract][Full Text] [Related]
4. Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial.
Byerly MJ; Nakonezny PA; Rush AJ
Psychiatry Res; 2008 May; 159(1-2):115-20. PubMed ID: 18295343
[TBL] [Abstract][Full Text] [Related]
5. [Generic quetiapine in the treatment of acute schizophrenia and schizoaffective disorder].
György B; Robert K; László C; Andrea J;
Neuropsychopharmacol Hung; 2008 Dec; 10(5):293-303. PubMed ID: 19419015
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia.
Lee KU; Jeon YW; Lee HK; Jun TY
Hum Psychopharmacol; 2009 Aug; 24(6):447-52. PubMed ID: 19606454
[TBL] [Abstract][Full Text] [Related]
7. Switching to quetiapine in patients with acute mania who were intolerant to risperidone.
Pae CU; Lee KU; Kim JJ; Lee CU; Bahk WM; Lee SJ; Lee C; Paik IH
Hum Psychopharmacol; 2004 Jan; 19(1):47-51. PubMed ID: 14716712
[TBL] [Abstract][Full Text] [Related]
8. An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms.
Timdahl K; Carlsson A; Stening G
Hum Psychopharmacol; 2007 Jul; 22(5):315-25. PubMed ID: 17542047
[TBL] [Abstract][Full Text] [Related]
9. [An open study on the efficacy and tolerability of quetiapine treatment of patients with schizophrenia].
Beszłej JA; Grzesiak M
Psychiatr Pol; 2005; 39(2):293-307. PubMed ID: 15881624
[TBL] [Abstract][Full Text] [Related]
10. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
11. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group.
McManus DQ; Arvanitis LA; Kowalcyk BB
J Clin Psychiatry; 1999 May; 60(5):292-8. PubMed ID: 10362435
[TBL] [Abstract][Full Text] [Related]
12. Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.
Rossi A; Bagalà A; Del Curatolo V; Scapati F; Bernareggi MM; Giustra MG;
Hum Psychopharmacol; 2009 Oct; 24(7):574-83. PubMed ID: 19790173
[TBL] [Abstract][Full Text] [Related]
13. Quetiapine: efficacy, tolerability and safety in schizophrenia.
Miodownik C; Lerner V
Expert Rev Neurother; 2006 Jul; 6(7):983-92. PubMed ID: 16831113
[TBL] [Abstract][Full Text] [Related]
14. A failed 6-week,randomized, double-blind, placebo-controlled study of once-daily extended release quetiapine fumarate in patients with acute schizophrenia: lessons learned.
Cutler AJ; Tran-Johnson T; Kalali A; Aström M; Brecher M; Meulien D
Psychopharmacol Bull; 2010; 43(4):37-69. PubMed ID: 21240151
[TBL] [Abstract][Full Text] [Related]
15. Treatment of depressive symptoms in patients with schizophrenia: a randomized, open-label, parallel-group, flexible-dose subgroup analysis of patients treated with extended-release quetiapine fumarate or risperidone.
Kasper S; Montagnani G; Trespi G; Di Fiorino M
Int Clin Psychopharmacol; 2015 Jan; 30(1):14-22. PubMed ID: 25356632
[TBL] [Abstract][Full Text] [Related]
16. Prolactin, subjective well-being and sexual dysfunction: an open label observational study comparing quetiapine with risperidone.
Westheide J; Cvetanovska G; Albrecht C; Bliesener N; Cooper-Mahkorn D; Creutz C; Hornung WP; Klingmüller D; Lemke MR; Maier W; Schubert M; Sträter B; Kühn KU
J Sex Med; 2008 Dec; 5(12):2816-26. PubMed ID: 18466271
[TBL] [Abstract][Full Text] [Related]
17. A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning.
Knegtering R; Castelein S; Bous H; Van Der Linde J; Bruggeman R; Kluiter H; van den Bosch RJ
J Clin Psychopharmacol; 2004 Feb; 24(1):56-61. PubMed ID: 14709948
[TBL] [Abstract][Full Text] [Related]
18. An open-label trial of quetiapine for antipsychotic-induced sexual dysfunction.
Byerly MJ; Lescouflair E; Weber MT; Bugno RM; Fisher R; Carmody T; Varghese F; Rush AJ
J Sex Marital Ther; 2004; 30(5):325-32. PubMed ID: 15672600
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy and tolerability of quetiapine in hospitalised schizophrenic patients during the acute treatment phase: a PMS study].
Leweke FM; Gerth CW; Koethe D; Nolden BM; Klosterkötter J
Fortschr Neurol Psychiatr; 2007 Apr; 75(4):211-9. PubMed ID: 17230308
[TBL] [Abstract][Full Text] [Related]
20. [Long-term relapse prevention with risperidone in 215 schizophrenic patients].
Udina Abelló C; Roca Bennasar M; Octavio Del Valle I
Actas Esp Psiquiatr; 2001; 29(4):243-9. PubMed ID: 11470059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]